Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ELAB stock hub

PMGC Holdings Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ELABis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
8.8M
NASDAQ
Market data

Live price

Current market quote for this ticker.

Current price
ELAB
In the news

Latest news · ELAB

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-107.3
P25 -105.6P50 -46.5P75 -3.1
ROIC-51.9
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ELAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
183
Groups with data
11
Currency
USD
Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

25
MetricValue
Cik
0001840563
Company name
PMGC Holdings Inc.
Country
United States
Country code
US
Cusip
73017P508
Employees
34
Employees Change
31%
Employees Change Percent
1,033.3
Enterprise value
$5.4M
Exchange
NASDAQ
Financial currency
USD
First seen
2026-05-09
Industry
Biotechnology
IPO Date
2023-11-21
Isin
US73017P5089
Last refreshed
2026-05-10
Market cap
$8.8M
Market cap category
Nano-Cap
Price
$1.98
Price currency
USD
Rev Per Employee
17,355.41x
Sector
Healthcare
Sic
2834
Symbol
ELAB
Website
https://pmgcholdings.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-87.92%
EV/Sales
9.13x
FCF yield
-72.36%
P/B ratio
0.02x
P/S ratio
14.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

12
MetricValue
Gross margin
-174.95%
Gross Profit
$-1M
Net Income
$-7.7M
Net Income Growth Years
0%
Pretax Margin
-1,313.33%
Profit Per Employee
$-227,877
ROA
-40.73
Roa5y
-63.39
ROCE
-79.8
ROE
-107.3
Roe5y
-169.2
ROIC
-51.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

4
MetricValue
Cagr1y
-98.97%
EPS Growth Years
2
Revenue Growth Years
0x
Revenue Growth3 Y
-8.34x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.05
Assets
$12.9M
Cash
$6.1M
Current Assets
$6.9M
Current Liabilities
$3.9M
Debt
$2.6M
Debt Equity
$0.34
Equity
$7.8M
Interest Coverage
-13.02
Liabilities
$5M
Long Term Assets
$6M
Long Term Liabilities
$1.1M
Net Cash
$3.4M
Net Cash By Market Cap
$38.89
Net Cash Growth
-14%
Net Debt Equity
$-0.44
Tangible Book Value
$4M
Tangible Book Value Per Share
$49.15
WACC
5.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.74
Net Working Capital
$-1.6M
Quick ratio
1.63
Working Capital
$2.9M
Working Capital Turnover
$0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Dividend Yield
0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
-98.97%
200-day SMA
78.12
50-day SMA
4.01
50-day SMA vs 200-day SMA
50under200
All Time High
499,118
All Time High Change
-100%
All Time High Date
2023-11-27
All Time Low
1.62
All Time Low Change
22.22%
All Time Low Date
2026-03-27
ATR
0.72
Beta
-0.28
Beta1y
6.75
Beta2y
2.66
Ch YTD
-94.43
High
2.14
High52
309.1
High52 Date
2025-08-22
High52ch
-99.36%
Low
1.97
Low52
1.62
Low52 Date
2026-03-27
Low52ch
22.22%
Ma50ch
-50.61%
Premarket Change Percent
-0.93
Premarket Price
$2.14
Premarket Volume
19,102
Price vs 200-day SMA
-97.47%
RSI
38.05
RSI Monthly
0.47
RSI Weekly
17.42
Sharpe ratio
-0.81x
Sortino ratio
-1.51
Tr YTD
-94.43
Tr1m
-42.61%
Tr1w
-21.12%
Tr3m
-81.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
$-7.1M
Operating margin
-1,207.2

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

9
MetricValue
Float
4,447,725%
Float Percent
99.94%
Shares Insiders
0.06%
Shares Institutions
0.24%
Shares Out
4,450,547
Shares Qo Q
72.23%
Short Float
9.32%
Short Ratio
0.02
Short Shares
9.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

64
MetricValue
Adjusted FCF
$-6.4M
Average Volume
1,723,375.75x
Bv Per Share
97.11
CAPEX
$-442,255
Ch1m
-42.61
Ch1w
-21.12
Ch1y
-98.97
Ch3m
-81.25
Ch6m
-98.48
Change
-8.33%
Change From Open
-7.04
Close
2.16
Days Gap
-1.39
Depreciation Amortization
96,663
Dollar Volume
606,982.9
Earnings Date
2026-05-14
Earnings Time
bmo
EBIT
$-7.1M
EBITDA
$-7M
EPS
$-381
F Score
1
FCF
$-6.4M
FCF EV Yield
-118.41x
FCF Per Share
$-1.43
Financing CF
10,116,738
Fiscal Year End
December
Founded
2,020
Goodwill
977,774
Income Tax
$30,972
Investing CF
-2,765,154
Ipr
-50.5
Iprfo
-100
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2025-11-14
Last Report Date
2025-12-31
Last Split Date
2026-03-10
Last Split Type
Reverse
Last10k Filing Date
2026-03-30
Ma150
54.84
Ma150ch
-96.39%
Ma20
2.96
Ma20ch
-33.2%
Net CF
1,417,880
Next Earnings Date
2026-05-22
Open
2.13
Optionable
No
Position In Range
5.88
Post Close
1.98
Postmarket Change Percent
0.51
Postmarket Price
$1.99
Ppne
2,127,047
Pre Close
2.16
Price Date
2026-05-08
Ptbv Ratio
2.22
Relative Volume
0.18x
Revenue
590,084x
SBC By Revenue
-3.25x
Share Based Comp
-19,160
Tax By Revenue
5.25x
Tr6m
-98.48%
Us State
California
Volume
306,557
Z Score
-3.37
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ELAB pay a dividend?

Capital-return profile for this ticker.

Performance

ELAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-99.0%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ELAB?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.2%
Float: +99.9% of shares outstanding
Insider ownership
+0.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+9.3%
0.0 days to cover
Y/Y dilution
n/a
Negative means the company is buying back shares.
Technical

ELAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.0
Neutral momentum band
Price vs 200-day MA
-97.5%
50/200-day relationship not available
Beta (5Y)
-0.28
Less volatile than the market
Sharpe ratio
-0.81
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ELAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ELAB stock rating?

PMGC Holdings Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ELAB analysis?

The full report lives at /stocks/ELAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ELAB?

The latest report frames ELAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ELAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.